De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Target Healthcare REIT Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kenneth MacKenzie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	14.8yrs
Gemiddelde ambtstermijn bestuur	2.7yrs

Recente managementupdates

Recent updates

Target Healthcare REIT PLC Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 16

What Type Of Shareholders Own The Most Number of Target Healthcare REIT PLC (LON:THRL) Shares?

Mar 16

Target Healthcare REIT PLC (LON:THRL) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Jan 22

CEO

Kenneth MacKenzie (74 yo)

no data

Tenure

Mr. Kenneth Macangus MacKenzie, MA, CA serves as Founder & Chief Executive of Target Fund Managers Limited, the Investment Manager of Target Healthcare REIT plc. Mr. MacKenzie founded the Target Advisers L...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kenneth MacKenzie	Founder & Chief Executive of Target Fund Managers Limited	no data	geen gegevens	geen gegevens
Gordon Bland	Finance Director of Target Fund Managers Limited	no data	geen gegevens	geen gegevens
John Flannelly	Head of Investment - Target Fund Managers Limited	14.8yrs	geen gegevens	geen gegevens
Andrew Brown	Head of Healthcare - Target Fund Managers Limited	14.8yrs	geen gegevens	geen gegevens
Scott Steven	Head of Asset Management - Target Fund Managers Limited	6.8yrs	geen gegevens	geen gegevens
Donald Cameron	Company Secretary & Director of Financial Reporting - Target Fund Managers Limited	no data	geen gegevens	geen gegevens

14.8yrs

Gemiddelde duur

Ervaren management: Het managementteam van THRL is doorgewinterd en ervaren (gemiddelde ambtstermijn van 14.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Cotton	Senior Independent Director	1.9yrs	UK£40.50k	0.0048% £ 26.8k
Michael Brodtman	Independent Non-Executive Director	1.8yrs	UK£40.50k	0.0039% £ 21.6k
James Niblett	Independent Non-Executive Director	3.2yrs	UK£47.25k	0.0039% £ 21.5k
Alison Fyfe	Independent Chairman of the Board	4.4yrs	UK£58.50k	0.0016% £ 8.9k
Amanda Thompsell	Independent Non-Executive Director	2.7yrs	UK£40.50k	geen gegevens

2.7yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van THRL wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.7 jaar), wat duidt op een nieuw bestuur.

Target Healthcare REIT Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Target Healthcare REIT PLC, Annual General Meeting, Dec 09, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Target Healthcare REIT PLC Appoints Michael Brodtman as an Independent Non-Executive Director, Effective 1 January 2023

Target Healthcare REIT PLC, Annual General Meeting, Dec 06, 2022

Target Healthcare REIT plc Announces Board Changes

Recent updates

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Target Healthcare REIT PLC, Annual General Meeting, Dec 09, 2024

Target Healthcare REIT PLC to Report Fiscal Year 2024 Results on Sep 17, 2024

Now 20% overvalued after recent price rise

Dividend of UK£0.014 announced

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Period from 1 April 2024 to 30 June, Payable on 30 August 2024

Now 19% overvalued

An undisclosed buyer acquired Four UK care homes from Target Healthcare REIT PLC (LSE:THRL) for £44.5 million.

Now 22% overvalued

Now 22% overvalued

Now 20% overvalued after recent price rise

Now 20% overvalued after recent price rise

Dividend of UK£0.014 announced

Target Healthcare REIT PLC Declares Third Interim Dividend for the Period from 1 January 2024 to 31 March 2024, Payable on 31 May 2024

First half 2024 earnings released: EPS: UK£0.05 (vs UK£0.055 loss in 1H 2023)

Target Healthcare REIT PLC to Report First Half, 2024 Results on Mar 12, 2024

Fourth quarter dividend of UK£0.014 announced

Target Healthcare Reit plc Declares Second Interim Dividend for the Period from 1 October 2023 to 31 December 2023, Payable on 23 February 2024

Now 20% undervalued

Now 20% undervalued

Now 21% undervalued

Now 20% undervalued

Target Healthcare REIT PLC Declares First Interim Dividend for the Period from 1 July 2023 to 30 September 2023, Payable on 24 November 2023

Full year 2023 earnings: EPS misses analyst expectations

Target Healthcare REIT PLC to Report Fiscal Year 2023 Results on Oct 10, 2023

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2023, Payable on August 25, 2023

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2023, Payable on 26 May 2023

First half 2023 earnings released: UK£0.055 loss per share (vs UK£0.032 profit in 1H 2022)

Now 21% undervalued after recent price drop

Target Healthcare REIT PLC Announces Second Interim Dividend for the Year Ending 30 June 2023, Payable on 24 February 2023

High number of new and inexperienced directors

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Target Healthcare REIT PLC Appoints Michael Brodtman as an Independent Non-Executive Director, Effective 1 January 2023

Target Healthcare REIT PLC, Annual General Meeting, Dec 06, 2022

Now 21% undervalued after recent price drop

Price target decreased to UK£0.97

Target Healthcare REIT PLC Announces First Interim Dividend for the Period ended September 30, 2022, Payable on 25 November 2022

Price target decreased to UK£0.97

Consensus forecasts updated

Target Healthcare REIT PLC Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Target Healthcare REIT plc Announces Board Changes

Price target decreased to UK£1.09

Price target decreased to UK£1.21

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2022, Payable on August 26, 2022

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2022, payable on 27 May 2022

Consensus EPS estimates fall by 17%

First half 2022 earnings: EPS exceeds analyst expectations

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Announces Appointment of Amanda Thompsell as an Independent Non-Executive Director

Target Healthcare REIT PLC (LSE:THRL) acquired Portfolio of 18 operational modern care homes in Weymouth.

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.072 in FY 2020)

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £125 million.

Price target decreased to UK£1.30

Target Healthcare REIT PLC (LSE:THRL) acquired Luxury Care Home in Scotland and a Development site in Buckinghamshire for £33 million.

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2021, Payable on 28 May 2021

First half 2021 earnings released: EPS UK£0.035 (vs UK£0.039 in 1H 2020)

What Type Of Shareholders Own The Most Number of Target Healthcare REIT PLC (LON:THRL) Shares?

Price target lowered to UK£1.30

New 90-day low: UK£1.11

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £60 million.

Target Healthcare REIT PLC (LSE:THRL) acquired Development site in Droitwich Spa.

New 90-day high: UK£1.17

Target Healthcare REIT PLC (LON:THRL) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

New 90-day high: UK£1.15

Full year earnings released